138 related articles for article (PubMed ID: 28275972)
1. Dihydropyrimidine Dehydrogenase Deficiency: Metabolic Disease or Biochemical Phenotype?
Fleger M; Willomitzer J; Meinsma R; Alders M; Meijer J; Hennekam RCM; Huemer M; van Kuilenburg ABP
JIMD Rep; 2017; 37():49-54. PubMed ID: 28275972
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyrimidine dehydrogenase deficiency in two malaysian siblings with abnormal MRI findings.
Chen BC; Mohd Rawi R; Meinsma R; Meijer J; Hennekam RC; van Kuilenburg AB
Mol Syndromol; 2014 Dec; 5(6):299-303. PubMed ID: 25565930
[TBL] [Abstract][Full Text] [Related]
3. Dihydropyrimidine Dehydrogenase Deficiency: Homozygosity for an Extremely Rare Variant in DPYD due to Uniparental Isodisomy of Chromosome 1.
van Kuilenburg ABP; Meijer J; Meinsma R; Pérez-Dueñas B; Alders M; Bhuiyan ZA; Artuch R; Hennekam RCM
JIMD Rep; 2019; 45():65-69. PubMed ID: 30349988
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin.
Fernandez-Salguero PM; Sapone A; Wei X; Holt JR; Jones S; Idle JR; Gonzalez FJ
Pharmacogenetics; 1997 Apr; 7(2):161-3. PubMed ID: 9170156
[TBL] [Abstract][Full Text] [Related]
5. Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12.
van Kuilenburg ABP; Tarailo-Graovac M; Meijer J; Drogemoller B; Vockley J; Maurer D; Dobritzsch D; Ross CJ; Wasserman W; Meinsma R; Zoetekouw L; van Karnebeek CDM
Hum Mutat; 2018 Jul; 39(7):947-953. PubMed ID: 29691939
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene.
Kuilenburg ABPV; Meijer J; Tanck MWT; Dobritzsch D; Zoetekouw L; Dekkers LL; Roelofsen J; Meinsma R; Wymenga M; Kulik W; Büchel B; Hennekam RCM; Largiadèr CR
Biochim Biophys Acta; 2016 Apr; 1862(4):754-762. PubMed ID: 26804652
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidine dehydrogenase deficiency caused by a novel genomic deletion c.505_513del of DPYD.
van Kuilenburg AB; Meijer J; Gökcay G; Baykal T; Rubio-Gozalbo ME; Mul AN; de Die-Smulders CE; Weber P; Mori AC; Bierau J; Fowler B; Macke K; Sass JO; Meinsma R; Hennermann JB; Miny P; Zoetekouw L; Roelofsen J; Vijzelaar R; Nicolai J; Hennekam RC
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):509-14. PubMed ID: 20544545
[TBL] [Abstract][Full Text] [Related]
8. Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.
Johnson MR; Wang K; Diasio RB
Clin Cancer Res; 2002 Mar; 8(3):768-74. PubMed ID: 11895907
[TBL] [Abstract][Full Text] [Related]
9. Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure.
van Kuilenburg AB; Dobritzsch D; Meinsma R; Haasjes J; Waterham HR; Nowaczyk MJ; Maropoulos GD; Hein G; Kalhoff H; Kirk JM; Baaske H; Aukett A; Duley JA; Ward KP; Lindqvist Y; van Gennip AH
Biochem J; 2002 May; 364(Pt 1):157-63. PubMed ID: 11988088
[TBL] [Abstract][Full Text] [Related]
10. Dihydropyrimidine dehydrogenase deficiency presenting at birth.
Al-Sanna'a NA; Van Kuilenburg AB; Atrak TM; Abdul-Jabbar MA; Van Gennip AH
J Inherit Metab Dis; 2005; 28(5):793-6. PubMed ID: 16151913
[TBL] [Abstract][Full Text] [Related]
11. Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio.
Thomas F; Hennebelle I; Delmas C; Lochon I; Dhelens C; Garnier Tixidre C; Bonadona A; Penel N; Goncalves A; Delord JP; Toulas C; Chatelut E
Clin Pharmacol Ther; 2016 Feb; 99(2):235-42. PubMed ID: 26265035
[TBL] [Abstract][Full Text] [Related]
12. An incidental case of dihydropyrimidine dehydrogenase deficiency: One case, multiple challenges.
Al Khallaf HH; He M; Wittenauer A; Woolley EE; Cunto M; Pervaiz MA
Indian J Hum Genet; 2013 Oct; 19(4):483-6. PubMed ID: 24497719
[TBL] [Abstract][Full Text] [Related]
13. Dihydropyrimidine dehydrogenase (DPD) deficiency: identification and expression of missense mutations C29R, R886H and R235W.
Vreken P; Van Kuilenburg AB; Meinsma R; van Gennip AH
Hum Genet; 1997 Dec; 101(3):333-8. PubMed ID: 9439663
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of dihydropyrimidine dehydrogenase deficiency in a neonate with thymine-uraciluria.
Au KM; Lai CK; Yuen YP; Shek CC; Lam CW; Chan AY
Hong Kong Med J; 2003 Apr; 9(2):130-2. PubMed ID: 12668826
[TBL] [Abstract][Full Text] [Related]
15. A neonate with recurrent vomiting and generalized hypotonia diagnosed with a deficiency of dihydropyrimidine dehydrogenase.
Brussel W; van Kuilenburg AB; Janssens PM
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1099-102. PubMed ID: 17065071
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyrimidine dehydrogenase deficiency presenting with psychomotor retardation in the first Polish patient.
Mazur A; Figurski S; Płoskoń A; Meijer J; Zoetekouw L; Watróbska S; Sykut-Cegielska J; Gradowska W; van Kuilenburg AB
Acta Biochim Pol; 2008; 55(4):787-90. PubMed ID: 19081848
[TBL] [Abstract][Full Text] [Related]
17. Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency.
Van Kuilenburg AB; Vreken P; Abeling NG; Bakker HD; Meinsma R; Van Lenthe H; De Abreu RA; Smeitink JA; Kayserili H; Apak MY; Christensen E; Holopainen I; Pulkki K; Riva D; Botteon G; Holme E; Tulinius M; Kleijer WJ; Beemer FA; Duran M; Niezen-Koning KE; Smit GP; Jakobs C; Smit LM; Van Gennip AH
Hum Genet; 1999 Jan; 104(1):1-9. PubMed ID: 10071185
[TBL] [Abstract][Full Text] [Related]
18. Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.
Meulendijks D; Henricks LM; van Kuilenburg AB; Jacobs BA; Aliev A; Rozeman L; Meijer J; Beijnen JH; de Graaf H; Cats A; Schellens JH
Cancer Chemother Pharmacol; 2016 Oct; 78(4):875-80. PubMed ID: 27544765
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.
Ezzeldin HH; Lee AM; Mattison LK; Diasio RB
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8699-705. PubMed ID: 16361556
[TBL] [Abstract][Full Text] [Related]
20. DPYD*2A mutation: the most common mutation associated with DPD deficiency.
Saif MW; Ezzeldin H; Vance K; Sellers S; Diasio RB
Cancer Chemother Pharmacol; 2007 Sep; 60(4):503-7. PubMed ID: 17165084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
